B-LNP/diABZI

N/A

Report date: 2024/04/01 14:31:08
NME

Base Information

Drug NameB-LNP/diABZI
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCluster of differentiation 47 blockersProgrammed death-ligand 1 blockersStimulator of interferon genes stimulants
TargetsStimulator of interferon genesCluster of differentiation 47Programmed death-ligand 1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A